TherapeuticsMD, Inc. — Director's Dealing 2019

Aug 31, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2019-08-28

Reporting Person: Donegan Michael C (Vice President Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-28	Non-Qualified Stock Option (right to buy)	$2.73	A	120000	Acquired	2029-08-28	Common Stock (120000)	Direct

Footnotes

F1: Underlying shares vest as follows: 40,000 shares on the first anniversary date of the grant, 40,000 shares on the second anniversary date of the grant, and 40,000 shares on the third anniversary date of the grant.